Retailers file US antitrust claims against Teva over Copaxone
MLex Summary: Walgreen, The Kroger, Albertsons Companies, and H-E-B filed a US complaint accusing Teva Pharmaceuticals of illegally delaying a generic competitor for multiple sclerosis treatment drug Copaxone. According to the complaint,...To view the full article, register now.
Already a subscriber? Click here to view full article